These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11519636)

  • 1. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.
    Rush CR; Baker RW
    Exp Clin Psychopharmacol; 2001 Feb; 9(1):59-73. PubMed ID: 11519636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
    Rush CR; Kollins SH; Pazzaglia PJ
    Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
    Sevak RJ; Stoops WW; Hays LR; Rush CR
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Rush CR; Baker RW; Rowlett JK
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):22-36. PubMed ID: 10743902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative-stimulus effects of modafinil in cocaine-trained humans.
    Rush CR; Kelly TH; Hays LR; Wooten AF
    Drug Alcohol Depend; 2002 Aug; 67(3):311-22. PubMed ID: 12127202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and physiological effects of cocaine in humans following triazolam.
    Haga JL; Baker RW; Rush CR
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):383-92. PubMed ID: 14643836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute behavioral and physiological effects of modafinil in drug abusers.
    Rush CR; Kelly TH; Hays LR; Baker RW; Wooten AF
    Behav Pharmacol; 2002 Mar; 13(2):105-15. PubMed ID: 11981223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
    Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
    Lile JA; Stoops WW; Durell TM; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
    Stoops WW; Glaser PE; Fillmore MT; Rush CR
    J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.
    Kollins SH; Rush CR; Pazzaglia PJ; Ali JA
    Exp Clin Psychopharmacol; 1998 Nov; 6(4):367-74. PubMed ID: 9861551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secobarbital in humans discriminating triazolam under two-response and novel-response procedures.
    Kamien JB; Bickel WK; Smith BJ; Badger GJ; Hughes JR
    Pharmacol Biochem Behav; 1997 Dec; 58(4):983-91. PubMed ID: 9408204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment.
    Roache JD; Grabowski J; Schmitz JM; Creson DL; Rhoades HM
    J Clin Psychopharmacol; 2000 Feb; 20(1):61-8. PubMed ID: 10653210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis.
    Rush CR; Baker RW; Wright K
    Drug Alcohol Depend; 1999 Jun; 55(1-2):1-12. PubMed ID: 10402144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
    Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR
    Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
    Rush CR; Stoops WW; Hays LR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
    Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR
    Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.